Medical device and MedTech insights, news, tips and more

Soft Robotics Inc. Appoints Mark J. Chiappetta as Chief Technology Officer

April 21, 2016

Soft Robotics Inc

Soft Robotics Inc

CAMBRIDGE, Mass., April 18, 2016 /PRNewswire/ — Soft Robotics Inc., an early stage robotics company, today announced that it has appointed Mark J. Chiappetta as its Chief Technology Officer.

Mr. Chiappetta is a high energy technology leader with over 20 years of experience in high growth, start-up and mid-size companies. He is an established inventor with over 30 issued and numerous additional pending patents in the field of robotics and automation, and remains proficient in the design, development, and manufacture of revolutionary products utilizing the latest in robotics technologies.

“Soft Robotics is addressing one of the most important needs in robotics technology, the ability to bring adaptability to robotic manipulation. This is a challenge not only to existing users of automation, but the novel soft robotics technology opens new markets to robotic solutions. A technology that allows robots to interact safely and reliably with everything from fresh cut produce, fresh baked foods, consumer goods, and automobile parts is what the market has been seeking for a long time. Soft Robotics is addressing that need and expanding what is possible with robots,” said Mr. Chiappetta.

Before joining Soft Robotics, Inc., Mr. Chiappetta spent 2.5 years at BIONX Medical Technologies as Senior Vice President of R&D where he oversaw the development of the BiOM robotic ankle-foot prosthetic and 15 years at iRobot Corporation in a variety of technical and leadership roles with his last being Vice President of iRobot’s Advanced Systems and Technology group. Earlier in his career, Mr. Chiappetta worked for Joseph F. Engelberger who is known world-wide as the “Father of Robotics.”

Read More – Source: Soft Robotics Inc. Appoints Mark J. Chiappetta as Chief Technology Officer

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.